open access
Omicron variants of the SARS-COV-2: A potentially significant threat in a new wave of infections
- Henry JN Taub Department of Emergency Medicine, Baylor College of Medicine Houston, Houston, TX, United States of America
- Institute of Outcomes Research, Maria Sklodowska-Curie Medical Academy, Warsaw, Poland
- Department of Trauma and Orthopedic Surgery, Ruda Slaska City Hospital, Ruda Slaska, Poland
- School of Medicine, International European University, Kyiv, Ukraine
- Department of Medical Education, Kirk Kerkorian School of Medicine at UNLV, University of Nevada, Las Vegas, Nevada, United States of America
- Office of Research, Kirk Kerkorian School of Medicine at UNLV, University of Nevada, Las Vegas, United States of America
- Office of Analytics, Nevada Department of Health and Human Services, Carson City, Nevada, United States of America
- Post-Graduate School of Occupational Health, Università Cattolica del Sacro Cuore, Rome, Italy
- Health Service Department, Italian State Police, Ministry of the Interior, Milan, Italy
- APHP, CHU Lariboisière, Department of Anesthesiology and Critical Care, FHU PROMICE, DMU Parabol, APHP.Nord, Paris, France, France
- Université de Paris, France
open access
Abstract
Abstract
Keywords
COVID-19; Omicron variants; SARS-CoV-2
Title
Omicron variants of the SARS-COV-2: A potentially significant threat in a new wave of infections
Journal
Disaster and Emergency Medicine Journal
Issue
Article type
Editorial
Pages
139-141
Published online
2022-09-21
Page views
7000
Article views/downloads
289
DOI
Bibliographic record
Disaster Emerg Med J 2022;7(3):139-141.
Keywords
COVID-19
Omicron variants
SARS-CoV-2
Authors
Lukasz Szarpak
Michal Pruc
Alla Navolokina
Kavita Batra
Francesco Chirico
Charles De Roquetaillade
- Dzieciatkowski T, Szarpak L, Filipiak KJ, et al. COVID-19 challenge for modern medicine. Cardiol J. 2020; 27(2): 175–183.
- Cao Y, Yisimayi A, Jian F, et al. BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection. Nature. 2022; 608(7923): 593–602.
- Tuekprakhon A, Nutalai R, Dijokaite-Guraliuc A, et al. OPTIC Consortium, ISARIC4C Consortium. Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum. Cell. 2022; 185(14): 2422–2433.e13.
- Khan K, Karim F, Ganga Y, et al. COMMIT-KZN Team. Omicron sub-lineages BA.4/BA.5 escape BA.1 infection elicited neutralizing immunity. medRxiv. 2022.
- Wang Q, Guo Y, Iketani S, et al. Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5. Nature. 2022; 608(7923): 603–608.
- Kimura I, Yamasoba D, Tamura T, et al. Virological characteristics of the novel SARS-CoV- Omicron variants including BA. 2 12 1, BA 4 and BA 5 bioRxiv 2022 05. ; 26: 493539.
- Centers for Disease Control and Prevention. COVID Data Tracker. Atlanta, GA: US Department of Health and Human Services, CDC. https://covid.cdc.gov/covid-data-tracker (17.07.2022).
- Wang Q, Guo Y, Iketani S, et al. Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5. Nature. 2022; 608(7923): 603–608.
- Reynolds CJ, Pade C, Gibbons JM, et al. Immune boosting by B.1.1.529 ( Omicron) depends on previous SARS-CoV-2 exposure. Science. 2022; 377(6603): eabq1841.
- Tracking SARS-CoV-2 variants. https://www.who.int/activities/tracking-SARS-CoV-2-variants?fbclid=IwAR0U5_OlEMMbuoYznxjUQfSiPiGwso1C-aeS5sXa_nSN9ILPnzGbj7wWQyw (17.07.2022).
- Ito K, Piantham C, Nishiura H. Relative instantaneous reproduction number of Omicron SARS-CoV-2 variant with respect to the Delta variant in Denmark. J Med Virol. 2022; 94(5): 2265–2268.
- Boucau J, Marino C, Regan J, et al. Duration of shedding of culturable virus in SARS-CoV-2 Omicron (BA.1) infection. N Engl J Med. 2022; 387(3): 275–277.
- Gagne M, Moliva JI, Foulds KE, et al. mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits comparable B cell expansion, neutralizing antibodies and protection against Omicron. bioRxiv. 2022: 479037.